Skip to main content
Log in

The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Akin S, Gucuk-Ipek E, Hayta U, et al. Long-term dexamethasone treatment increases cardiac galectin-3 levels. Cardiovasc Drugs Ther. 2022. https://doi.org/10.1007/s10557-022-07344-w.

  2. Ospina-Quintero L, Jaramillo JC, Tabares-Guevara JH, Ramírez-Pineda JR. Reformulating small molecules for cardiovascular disease immune intervention: low-dose combined vitamin D/dexamethasone promotes IL-10 production and atheroprotection in dyslipidemic mice. Front Immunol. 2020;11:743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wang H, Yao X, Huang K, et al. Low-dose dexamethasone in combination with luteolin improves myocardial infarction recovery by activating the antioxidative response. Biomed Pharmacother. 2022;151:113121.

    Article  CAS  PubMed  Google Scholar 

  4. Tao Z, Loo S, Su L, et al. Dexamethasone inhibits regeneration and causes ventricular aneurysm in the neonatal porcine heart after myocardial infarction. J Mol Cell Cardiol. 2020;144:15–23.

    Article  CAS  PubMed  Google Scholar 

  5. de Salvi GF, de Moraes WM, Bozi LH, et al. Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation. Mol Cell Biochem. 2017;424(1-2):87–98.

    Article  Google Scholar 

Download references

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to De-Gang Mo.

Ethics declarations

Conflict of Interests

The authors report no relationships that could be construed as a conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, QF., Liu, JH. & Mo, DG. The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?. Cardiovasc Drugs Ther 37, 847–848 (2023). https://doi.org/10.1007/s10557-022-07375-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-022-07375-3

Navigation